State of the Art Ovarian Cancer Conference 2016

Advances in women’s health research provide important opportunities to enhance the screening and prevention of ovarian cancer. New modalities in the treatment of the disease provide the ability to individualize therapy, accomplish best clinical outcomes, and optimize the patient experience.

The target audience includes all clinicians, scientists and advocates interested in women’s health, and in optimizing the prevention, screening and treatment for ovarian cancer.  Clinicians including OB/GYNs, surgical/medical/gynecologic oncologists, primary care physicians, physician assistants, nurse practitioners, nurses, fellows and residents and other healthcare professionals are welcome.

Sponsors

This activity is supported by educational grants from:

• Medtronic
• Myriad Genetic Laboratories
• ThermaSolutions, Inc

1. Discuss new genetic panel testing and its implication, results of recent ovarian cancer screening trial, and strategies for ovarian cancer risk-reduction.
2. Present new algorithms for imaging and surgical case selection.
3. Evaluate emerging opportunities in clinical trial options, individualized treatment, and enhanced patient experience.

*Industry Members: Registration is for educational purposes only. Marketing, sales, and promotion of products and services are prohibited at CME activities.
*MSK Alliance Members: If you are a MSK Alliance member, please email us at [email protected] with your affiliation for discount information.

Special CME Discount 

If you register for this course, you will also receive a discounted rate for our Intraoperative Imaging Technologies for Cancer Detection and Treatment course.  A promo code will emailed to you after registering

Advocacy Groups

If you are interested in attending this course in a group of 4 with opportunity to provide participants information regarding your organization during the course, please contact [email protected] or call 646-227-2025 for more information.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Accommodations

For information on hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/accommodations.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Directors

Ginger J. Gardner, MD, FACOG
Kara Long Roche, MD, MSc, FACOG

Faculty

Thursday, October 6, 2016